148 related articles for article (PubMed ID: 34611073)
1. COVID Arm After Moderna Booster in Healthcare Worker: A Case Report.
Saifuddin A; Koesnoe S; Kurniati N; Sirait S; Arisanty R; Yunihastuti E
Acta Med Indones; 2021 Jul; 53(3):326-330. PubMed ID: 34611073
[TBL] [Abstract][Full Text] [Related]
2. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
Johnston MS; Galan A; Watsky KL; Little AJ
JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
4. Impact of COVID-19 vaccine-associated side effects on health care worker absenteeism and future booster vaccination.
Chrissian AA; Oyoyo UE; Patel P; Lawrence Beeson W; Loo LK; Tavakoli S; Dubov A
Vaccine; 2022 May; 40(23):3174-3181. PubMed ID: 35465979
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
[TBL] [Abstract][Full Text] [Related]
6. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
7. Delayed localized hypersensitivity reactions to COVID-19 mRNA vaccines: a 6-month retrospective study.
Papadimitriou I; Bakirtzi K; Sotiriou E; Vakirlis E; Hatzibougias D; Ioannides D
Clin Exp Dermatol; 2022 Jan; 47(1):157-158. PubMed ID: 34288056
[TBL] [Abstract][Full Text] [Related]
8. Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports.
Mustafa SS; Ramsey A; Staicu ML
Ann Intern Med; 2021 Aug; 174(8):1177-1178. PubMed ID: 33819057
[No Abstract] [Full Text] [Related]
9. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.
Lindgren AL; Austin AH; Welsh KM
J Prim Care Community Health; 2021; 12():21501327211024431. PubMed ID: 34120504
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
11. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835
[TBL] [Abstract][Full Text] [Related]
12. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
13. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
[TBL] [Abstract][Full Text] [Related]
14. [Allergic reactions to COVID-19 vaccines].
Geersing TH; Tempels-Pavlica Ž; Borgsteede SD
Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651507
[TBL] [Abstract][Full Text] [Related]
15. Fever-Related Ventricular Fibrillation - Potential Adverse Effect of SARS-CoV-2 Vaccination in Patients With Brugada Syndrome.
Kokawa T; Yamamoto H; Itoh M; Shimane A; Kawai H; Takaya T
Circ J; 2022 Feb; 86(3):474. PubMed ID: 34615807
[No Abstract] [Full Text] [Related]
16. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.
;
MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(4):125-129. PubMed ID: 33507892
[TBL] [Abstract][Full Text] [Related]
17. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
[TBL] [Abstract][Full Text] [Related]
18. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
[TBL] [Abstract][Full Text] [Related]
19. Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12-15 years.
King H; Deshpande S; Woodbridge T; Hilliard T; Standing J; Lewis M; Ward L; Finn A; Roderick M
Arch Dis Child; 2022 Feb; 107(2):205-207. PubMed ID: 34446440
[No Abstract] [Full Text] [Related]
20. Side effects after COVID-19 vaccinations among residents of Poland.
Andrzejczak-Grządko S; Czudy Z; Donderska M
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
